Shared on 30 Apr 25
Fair value Increased 4.23%AnalystHighTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Fair value Increased 5.01%AnalystHighTarget made no meaningful changes to valuation assumptions.
Loading...
Aging Populations And Biotech Breakthroughs Will Drive Expansion
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
-3.8%7D
7.1%1Y
-3.8%7D
7.1%You can edit this narrative until May 12 6:01 AM. Then, changes will post as Updates.